ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

Dingell Subcommittee Report Next Month To Include New Info

July 1, 1994

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997

CCRAC Approves New Grant Program For Studies Of Cancer Patient Compliance RFA to Be Issued

May 16, 1980

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

February 23, 1996

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980